دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )

Slides:



Advertisements
Similar presentations
Vienna, Austria 4 September 2014 Stefano Berterame, Chief Narcotics Control and Estimates Section Secretariat of the International Narcotics Control Board.
Advertisements

Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
MaineCare’s New Medication Assisted Treatment (MAT)/Methadone Maintenance Therapy (MMT) Policy Kevin S. Flanigan, MD Medical Director Office of MaineCare.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
MaineCare & Opioid Treatment Where we are… How we got here… Where we are going… Kevin S. Flanigan, MD Medical Director Office of MaineCare Services.
Forensics/Harrison.  DEA Drug Schedule Site DEA Drug Schedule Site.
Palliative Care in the Nursing Home. Objectives Develop an awareness of how a palliative care environment can be created. Recognize the need for changes.
DOCUMENTATION AND AUTHENTICATION Introduction: The medical worker must pay care and attention to this aspect due its paramount importance. He must carefully.
DEALING WITH GOVERNMENT SCRUTINY OF PAIN MANAGEMENT BY PRIMARY CARE PHYSICIANS How To Anticipate And Avoid Government Interference With This Crucial Area.
The Nurse Practice Act.  Defines the Nurse Practice Act and its function  Describes how the Nurse Practice Act applies to the RN Scope of Practice Objectives.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 4 Prescription Writing.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Scope of Practice and Licensure
Medical Professionals’ Conversations About Care At the End of Life Joanna K. Weinberg, JD, LLM UC San Francisco UC Hastings College of the Law.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Pain Management And Prescribing Controlled Drugs Timothy J. Benedict, RPh Assistant Executive Director Ohio State Board of Pharmacy
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Opioid Risk Management Programs Celia Jaffe Winchell, M.D. Acting Deputy Division Director Division of Anesthetic, Critical Care, and Addiction Drug Products.
Federal Laws CHAPTER 3. DRUG REGULATION Timeline highlights –Food Drug & Cosmetic (FDC) Act –Durham Humphrey Amendment –Poison Prevention Packaging Act.
Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. The Pharmacy Technician: Foundations and Practices.
POLST and Hospice An Update for Oregon Gary Plant MD FAAFP Madras Medical Group Oregon POLST Task Force Oregon Academy of Family Physicians.
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Rx Abuse in Workers’ Compensation
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
Drug Regulations & Control
LECTURE FOR ASSIGNMENT 1 AND 2
5-1 ©2011, 2008 Pearson Education, Inc. Upper Saddle River, NJ FORENSIC SCIENCE: An Introduction, 2 nd ed. By Richard Saferstein Drug-Control Laws.
Washington’s Pain Management Rules April 22, 2013 Kristi Weeks, Director, Office of Legal Services Washington Department of Health.
Classification of Drugs bsapp.com. Abuse Inappropriate use Inappropriate use Unwarranted use Unwarranted use Over use Over use May or may not mean addiction.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
An Introduction to Medical Ethics Christopher DeMella, Pharm.D. PGY2 Academic Pharmacy Resident VCU School of Pharmacy Spring Semester, 2016.
Drug Enforcement Administration Greater Kansas City Chapter American Society for Pain Management Nursing October 24, 2015 Judy R. Williams Group Supervisor.
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
Medication Assisted Treatment
Declaration of Miami Joining forces for better pain treatment and promotion of pain medicine throughout the world.
Wireless Access SSID: cwag2017
Legal and Regulatory Issues in Pain Management
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
Classification of Drugs
Medical Practice Acts and State Boards
Drug-Control Laws The U.S. federal law known as the Controlled Substances Act will serve to illustrate a legal drug-classification system created to prevent.
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Federal Regulations requirements for opioid prescription course
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
DATA 2000 Waivers The Drug Addiction Treatment Act of 2000 (DATA 2000) permits physicians who meet certain qualifications to treat opioid dependency with.
Prescription Drug Monitoring Program
By Alan I. Kaplan, Attorney at Law
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Prescription Drug Monitoring Program
Drugs Jan 2018.
Regulation The legislation that is meant to regulate and control
Treating Anxiety From an Integrated Approach
5-3 Drug Control Laws October 8, 2019
Presentation transcript:

دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )

 painrelated laws have not kept pace with advances in medical and scientific understanding  This has particular implications for treating pain with opioids  clinicians generally do not receive training in legal and regulatory issues related to opioid prescribing, and are not familiar with the federal and state laws  Controlled substances laws govern the distribution of prescription medications  closed distribution system to minimize their abuse, trafficking, and diversion

 “Controlled substances” status of any medication is not intended to diminish its medical usefulness or create the perception that practitioners should avoid its use when appropriate

 The CSA specifies five classification schedules for controlled substances: - Schedule I controlled substances (e.g.,heroin, LSD, and marijuana) have no currently accepted medical use - Drugs that have an approved medical use are placed in Schedules II through V according to potential for abuse - Schedule II controlled substances in medical emergencies under specific circumstances

 Treating Addiction versus Treating Pain  methadone,a Schedule II medication approved for the purpose of addiction treatment, also can be prescribed as an analgesic according to the same laws

 health-care regulatory boards (e.g., medical, osteopathic, pharmacy, and nursing) in some states have worked together to adopt joint guidelines for pain management, palliative care, and end-of-life care.  Inadequately treated pain is a multifactorial phenomenon  insufficient to guarantee patient access to appropriate pain relief and symptom control  Health-care practitioners increasingly have assumed a leadership role in collaborating that avoids undue restrictions, recognizes the professional obligation to treat pain, and promotes effective patient pain care

 pain management usually involve allegations that excessive prescribing of opioids either lead to patient’s untimely death and therefore constituted homicide, or that the prescriptions had no legitimate medical purpose

 policy change actions improve laws  Health-care institutions and professionals are now on notice that pain management must be a priority in patient care